The signing of the Inflation Reduction Act in August of 2022 brought some immediate relief for Americans with Medicare prescription drug coverage and will continue to drastically impact drug prices as implementation continues. Already in effect as of January 2023: a $35 cap per month on insulin for Medicare prescription plan enrollees, Medicare beneficiaries receive…